(Q40533802)

English

Relative replication fitness of multi-nucleoside analogue-resistant HIV-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and mutations at codons 67 and 215.

scientific article published on August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Relative replication fitness of multi-nucleoside analogue-resistant HIV-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and mutations at codons 67 and 215. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Miguel A Martinez

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Javier Martinez-Picado

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bonaventura Clotet Sala

5

object named as

Bonaventura Clotet

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Luis Menéndez-Arias

6

object named as

Luis Menéndez-Arias

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

object named as

Julia G Prado

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Sandra Franco

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Tania Matamoros

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Lidia Ruiz

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

326

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

103-112

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Phenotypic susceptibilities to tenofovir in a large panel of clinically derived human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Fitness of human immunodeficiency virus type 1 protease inhibitor-selected single mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Multidrug-resistant HIV-1 reverse transcriptase: involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DN

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Human immunodeficiency virus reverse transcriptase and protease sequence database

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

An RNA virus can adapt to the multiplicity of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Stable rearrangements of the beta3-beta4 hairpin loop of HIV-1 reverse transcriptase in plasma viruses from patients receiving combination therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

based on heuristic

inferred from DOI database lookup

Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.006

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2004.06.006

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40533802&oldid=1747699303"